Moon, et al. found that overexpressing CD133 could up-regulate the expression of N-cadherin and vimentin, while down-regulate the expression of E-cadherin to promote the development of EMT and enhance the invasion and migration abilities of squamous cell carcinoma 34. Here, VIM is linked to squamous cell carcinoma.